Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Foley

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Kidney International|December 9, 1998
Long-term evolution of cardiomyopathy in dialysis patientsR N Foley, P S Parfrey, G M Kent, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1996
Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.
Kidney International|May 1, 1996
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.
Journal of the American Society of Nephrology : JASN|June 1, 1995
The prognostic importance of left ventricular geometry in uremic cardiomyopathyR N Foley, P S Parfrey, J D Harnett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1996
The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.
Postgraduate Medical Journal|October 28, 2006
Prevalence of hypogonadism in male patients with renal failureF Albaaj, M Sivalingham, P Haynes, et al.
Journal of the American Society of Nephrology : JASN|April 4, 1998
Mode of dialysis therapy and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.
Transplantation|November 15, 1995
Impact of renal transplantation on uremic cardiomyopathyP S Parfrey, J D Harnett, R N Foley, et al.
Diabetologia|December 6, 1997
Cardiac disease in diabetic end-stage renal diseaseR N Foley, B F Culleton, P S Parfrey, et al.
Kidney International|January 1, 1995
Clinical and echocardiographic disease in patients starting end-stage renal disease therapyR N Foley, P S Parfrey, J D Harnett, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Kidney International|December 9, 1998
Long-term evolution of cardiomyopathy in dialysis patientsR N Foley, P S Parfrey, G M Kent, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1996
Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.
Kidney International|May 1, 1996
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.
Journal of the American Society of Nephrology : JASN|June 1, 1995
The prognostic importance of left ventricular geometry in uremic cardiomyopathyR N Foley, P S Parfrey, J D Harnett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1996
The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.
Postgraduate Medical Journal|October 28, 2006
Prevalence of hypogonadism in male patients with renal failureF Albaaj, M Sivalingham, P Haynes, et al.
Journal of the American Society of Nephrology : JASN|April 4, 1998
Mode of dialysis therapy and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.
Transplantation|November 15, 1995
Impact of renal transplantation on uremic cardiomyopathyP S Parfrey, J D Harnett, R N Foley, et al.
Diabetologia|December 6, 1997
Cardiac disease in diabetic end-stage renal diseaseR N Foley, B F Culleton, P S Parfrey, et al.
Kidney International|January 1, 1995
Clinical and echocardiographic disease in patients starting end-stage renal disease therapyR N Foley, P S Parfrey, J D Harnett, et al.
Pageof 6